InsiderTrades

Form 4 for JNJ Johnson & Johnson

Accepted 2025-08-25 19:12:16 ET · period of report 2025-08-22 · accession 0000200406-25-000182 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-08-25 19:12 2025-08-22 JNJ Duato Joaquin CEO, COB, Dir M - OptEx $101.87 +125.8K 401.8K +46% +$12.82M
D 2025-08-25 19:12 2025-08-22 JNJ Duato Joaquin CEO, COB, Dir S - Sale+OE $179.21 -125.8K 276.0K -31% -$22.55M
D 2025-08-25 19:12 2025-08-22 JNJ Duato Joaquin CEO, COB, Dir M - OptEx $101.87 -125.8K 0 -100% -$12.82M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-22 M A 125,824 $101.87 401,791 D — —
2 Common Common Stock 2025-08-22 S D 125,824 $179.21 275,967 D — — (F1) This transaction was executed in multiple trades at prices ranging from $178.985 to $179.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Derivative Employee Stock Options (Right to Buy) 2025-08-22 M D 125,824 $101.87 0 D $101.87 · 2019-02-09 to 2026-02-08 125,824 Common Stock (F3) Vested and exercisable one day after the third anniversary of the date of the grant.